AGREF yields 2500.00% · MRK yields 2.81%● Live data
📍 AGREF pulled ahead of the other in Year 1
Combined, AGREF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AGREF + MRK for your $10,000?
Argonaut Resources NL operates as a mineral exploration and development company in Zambia and Australia. It primarily explores for iron oxide, lithium, uranium, copper, gold, cobalt, and nickel deposits. The company holds 90% interests in the Lumwana West project comprising one exploration licence; the Kamapanda project consisting of one exploration licence and covering an area of 225 square kilometers; and the Kalaba East project located in North-Western province, Zambia. It also has 80% interest in the Higginsville joint venture project covering one exploration licence located in the Eastern Goldfields of Western Australia; and holds 100% interest in the Murdie project comprising two exploration licence covering an area of 1,105 square kilometers located in Eastern Gawler Craton of South Australia. In addition, the company holds interest in the Torrens joint venture project covering one exploration licence; and the Frome project comprising three exploration licence covering an area of 2,894 square kilometers located in South Australia. Further, it holds 100% interest in the Kroombit project consisting of ML 5631 and the surrounding mineral development licence MDL 2002 located in Queensland; and the Aroona project comprising one exploration licence located in Southern Willouran Ranges, South Australia. The company was formerly known as Star Mining Corporation NL. Argonaut Resources NL was incorporated in 1985 and is based in Adelaide, Australia.
Full AGREF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.